Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions.

van Hunsel, Florence; de Jong, Emma; Gross-Martirosyan, Liana; Hoekman, Jarno

van Hunsel, Florence; de Jong, Emma; Gross-Martirosyan, Liana; Hoekman, Jarno.

van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's Hertogenbosch, The Netherlands.
de Jong E; Netherlands Pharmacovigilance Centre Lareb, 's Hertogenbosch, The Netherlands.
Gross-Martirosyan L; Utrecht University, Utrecht, The Netherlands.
Hoekman J; Medicines Evaluation Board, Utrecht, The Netherlands.

Pharmacoepidemiol Drug Saf ; 30(8): 1115-1122, 2021 08.

Article en En | MEDLINE | ID: mdl-33840136

Asunto(s)

Sistemas de Registro de Reacción Adversa a Medicamentos; Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos; Estudios de Cohortes; Humanos; Farmacovigilancia

Palabras clave

drug safety signals; marketing authorization; national competent authorities; pharmacoepidemiology; pharmacovigilance; spontaneous reporting system

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas de Registro de Reacción Adversa a Medicamentos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google